Skip to main content
18 February 2019
Last updated:
Monday 18 February 2019

User account menu

  • Log in
  • Register & Subscribe

Search this site:

 

Primary links

  • Home
  • News
  • About MedNous
  • Research Directory
  • Contact Us

John Haurum becomes chairman of Synklino

Tuesday 8 January 2019
Company
Synklino ApS
Appointee Name
John 
Haurum
Country

Denmark

John Haurum, formerly chief executive of the UK biotech F-star, has been named executive chairman of Synklino ApS. Based in Copenhagen, Denmark, Synklino is developing therapies to treat cytomegalovirus infections in transplant patients. Dr Haurum led drug discovery at F-star while helping raise more than €200 million in equity and non-dilutive funding for the company.

Synklino ApS announced the appointment on 3 January 2019.

Copyright 2019 Evernow Publishing Ltd

 

Select a News Category

  • Clinical Research
  • Company News
  • Finance, Grants, Deals
  • IPR & Legal
  • Regenerative Medicine
  • Regulation & Policy
  • Research & University News

Recent Appointments

Donato Spota to become CFO at Hansa Biopharma
Thursday February 7 2019
Georgia Gavriilidou joins Sidley Austin
Thursday February 7 2019
Alan Knox becomes CEO at Primex
Thursday February 7 2019
Kiadis appoints Robert Friesen as CSO
Thursday February 7 2019
Samantha Paston to head research at Scancell
Thursday February 7 2019

© 2018 Evernow Publishing Ltd. Powered by Drupal.